MENU
SEP 17, 2020 12:45 PM EDT

Stimuli-responsive Nanomaterials for Imaging Immunotherapy Response

Speaker

Abstract

Immunotherapy such as immune checkpoint inhibitor antibodies have revolutionized the treatments for hard-to-treat cancers, with durable responses observed in clinics. However, the overall response is observed only in a small subset of patients. Also, immunotherapy induces delayed on-set of responses and novel patterns of the anti-tumor response which makes it challenging to identify patient responders and non-responders early on, often leading to undertreatment or overtreatment. To address these challenges, we engineered a ‘stimuli-responsive nanomaterial’ (SRN) that can not only deliver an immune checkpoint inhibitor to the tumor but also report back on its efficacy in real time. We rationalized that this could be achieved by a novel two-staged stimuli-responsive polymeric nanomaterial with well-defined ratio of an immunotherapy drug and a drug-function activatable imaging agent. To accomplish this, we engineered a stimuli-responsive nanomaterial which comprises of three building blocks: an immunotherapy drug (anti-PDL1 antibody), an enzyme activatable imaging agent and a polymeric backbone that holds both elements together. In preliminary studies, we observed that anti-PD-L1 antibody conjugated SRNs inhibited PD1-PDL1 interactions efficiently and induced T-cell mediated cancer cell apoptosis that can be imaged using activatable imaging probe. SRNs not only enabled real-time immunotherapy response imaging in tumor bearing mice but also distinguished between highly responsive and partially responsive tumors. Furthermore, increasing doses resulted in better response and enhanced sensitivity in partially responsive tumors. This study shows that the treatment with SRNs induced a potent anti-tumor immune response that can be directly imaged and is more effective in imaging response than current agents.


Show Resources
You May Also Like
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
SEP 17, 2021 12:00 PM CST
C.E. CREDITS
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
MAY 11, 2021 10:00 AM PDT
C.E. CREDITS
MAY 11, 2021 10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
OCT 20, 2021 10:00 AM PDT
C.E. CREDITS
OCT 20, 2021 10:00 AM PDT
Date: October 20, 2021 Time:10:00am (PDT), 1:00pm (EDT) As the prevalence of Diabetes continues to rise in many areas across the globe, healthcare providers continue to look for methods that...
JUN 09, 2021 7:00 AM PDT
C.E. CREDITS
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
OCT 12, 2021 9:00 AM PDT
C.E. CREDITS
OCT 12, 2021 9:00 AM PDT
Date: October 12, 2021 Time: 9:00am (PDT), 12:00pm (EDT) SCIEX’s next-generation Biologics Explorer software is an innovative platform for the comprehensive and deep characterization o...
Loading Comments...
Show Resources